BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7915067)

  • 21. [Hemodynamic, anti-ischemic, metabolic and neurohumoral effects of enoximone (MDL 17,043) in patients with coronary disease].
    Mitrovic V; Schlepper M; Neuzner J; Bahavar H; Volz M; Dieterich HA
    Z Kardiol; 1988 Oct; 77(10):660-7. PubMed ID: 2977029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Gallopamil and molsidomine in patients with coronary heart disease. A comparative study].
    Zebe H
    Fortschr Med; 1989 Feb; 107(5):134-8. PubMed ID: 2651251
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Dose-response relation of gallopamil in comparison with nifedipine, diltiazem and tiapamil in patients with coronary heart disease].
    Hopf R; Fleischer K; Forster A; Mohler C; Schulz PC; Kaltenbach M
    Z Kardiol; 1989; 78 Suppl 5():69-76. PubMed ID: 2698566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Exercise capacity of coronary heart disease patients in long-term follow-up with gallopamil in comparison with premedication with verapamil].
    Reiterer W
    Z Kardiol; 1989; 78 Suppl 5():63-8. PubMed ID: 2517157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of chronotropic incompetence and beta-blocker use on the exercise treadmill test in men.
    Gauri AJ; Raxwal VK; Roux L; Fearon WF; Froelicher VF
    Am Heart J; 2001 Jul; 142(1):136-41. PubMed ID: 11431669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol.
    Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK
    Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The effect of gallopamil and propranolol in patients with ischemic cardiopathy and moderate depression of ventricular function].
    Simarro E; Rodríguez MA; Bayón J; Lastra JA; Prieto P; Suárez G; García Porrero E; Fernández R; Garrido J; Velasco J
    Rev Esp Cardiol; 1995 Nov; 48(11):741-5. PubMed ID: 8532943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of the cardiodepressive effects of nifedipine, isradipine, nisoldipine and felodipine in patients with coronary heart disease].
    Mauser M; Voelker W; Ickrath O; Karsch KR
    Z Kardiol; 1993 Jan; 82(1):17-27. PubMed ID: 8470415
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of L-carnitine in patients with ischemic heart disease].
    Fujiwara M; Nakano T; Tamoto S; Yamada Y; Fukai M; Takada K; Ashida H; Shimada T; Ishihara T; Seki I
    J Cardiol; 1991; 21(2):493-504. PubMed ID: 1841935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myocardial protection: the efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent.
    Bessho R; Chambers DJ
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):993-1003. PubMed ID: 11689806
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Esmolol hydrochloride: an ultrashort-acting, beta-adrenergic blocking agent.
    Angaran DM; Schultz NJ; Tschida VH
    Clin Pharm; 1986 Apr; 5(4):288-303. PubMed ID: 2871961
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine].
    Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M
    Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Alinidine in multi-vessel coronary disease: reduction of stress-induced ischemic reaction].
    Ditter H; Müller KD; Bahavar H; Schlepper M
    Z Kardiol; 1991 Feb; 80(2):167-70. PubMed ID: 2058248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of coronary blood flow during exercise.
    Duncker DJ; Bache RJ
    Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects of esmolol in anesthetized humans.
    Menkhaus PG; Reves JG; Kissin I; Alvis JM; Govier AV; Samuelson PN; Lell WA; Henling CE; Bradley E
    Anesth Analg; 1985 Mar; 64(3):327-34. PubMed ID: 2858169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of esmolol and dexmedetomidine on myocardial oxygen consumption during sympathetic stimulation in dogs.
    Willigers HM; Prinzen FW; Roekaerts PM
    J Cardiothorac Vasc Anesth; 2006 Jun; 20(3):364-70. PubMed ID: 16750737
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Esmolol versus diltiazem in the treatment of postoperative atrial fibrillation/atrial flutter after open heart surgery.
    Mooss AN; Wurdeman RL; Mohiuddin SM; Reyes AP; Sugimoto JT; Scott W; Hilleman DE; Seyedroudbari A
    Am Heart J; 2000 Jul; 140(1):176-80. PubMed ID: 10874282
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [An ergometric cross-over evaluation of the anti-ischemic efficacy of amlodipine and gallopamil in stable angina of effort].
    Perticone F; Borelli DA; Pugliese F; Maio R; Costa R; Cosco C; Ceravolo R; Mattioli PL
    Cardiologia; 1993 Jul; 38(7):455-62. PubMed ID: 8221740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of intravenous milrinone in chronic symptomatic ischemic heart disease.
    Mitrovic V; Stöhring R; Schlepper M
    Am Heart J; 1991 Jun; 121(6 Pt 2):1983-94. PubMed ID: 1827940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.